Following molecular characterization of PIK3CA‐H1047R tumors, we identified different pathways induced in the mutant tumors in comparison with tumors which have an activated, but wild‐type PI3K pathway, such as mammary tumors from the MMTV‐Her2 mice. The gene discussed is ERBB2; the disease is breast cancer.